Avendaño RJM, Jaramillo RHJ, Rodríguez LM

Language: Spanish
References: 13
Page: 431-436
PDF size: 294.77 Kb.

ABSTRACT

Background: The development of stress ulcer in patients who have had such stressful events it is a well-known entity, nevertheless, from the appearance of the medicaments that increase the gastric pH, the incident of these has diminished. Making clinical use of these inflated estimates has patient care implications and cost implications, because stress ulcer prophylaxis adds to the number of medications given and increases the risk and cost of adverse reactions.
Objective: The present study tries to demonstrate that the overuse of the inhibiting of acid gastric secretion like prevention for stress ulcer in a hospital of The Mexicali’s second level.
Material and method: The study is retrospective, observational, of the patients’ clinical processes of the General Hospital of Mexicali, of patients hospitalized in the services of internal medicine, surgery, emergency room, and intensive therapy in the from June to September, 2009.
Results: 828 patients were included, the percentage that received inadequate therapy they were 73 % of emergency room, 62 % surgery, 42.85 % of medicine hospitalized and 12 % of UCI. The total cost for inadequate prevention was 77,415.52 weight.
Conclusions: The difference in the inadequate prescription on the part of the different services, can be related to the preparation of the personal scholar and assigned.

REFERENCES

1. Schuster DP. Stress ulcer prophylaxis: in whom? With what? Crit Care Med 1993;21:4-6.

2. Schuster DP. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med 1984; 76:623-663.

3. Duerksen DR. Stress-related mucosal disease in critically ill patients Best pract clin gastroenterol 2003;17:327-344.

4. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, et al. Risk factors for gastrointestinal bleeding in critically Ill Patients. NEJM 1994;330:377-381.

5. American Society of Health-System Pharmacists Commission on Therapeutics. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm 1999;56:347-379.

6. Daley RJ, Rebuck JA, Frederick LSB. Prevention of stress ulceration: Current trends in critical care. Crit Care Med 2004;32:2008-2013.

7. Quenot JP, Mentec H, Fihl, et al. Bedside adherence to clinical practice guidelines in the intensive care unit: the TECLA study. Intensive Care Med 2008;34:1293-1400.

8. Shuster DP, Rowley H, Feinstein S, et al. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med 1984;13:635-650.

9. Cook D, Heyland D, Griffith L, et al. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Crit Care Med 1999;2812-2817.

10. Pimentel M, Roberts DE, Bernstein CN, Hoppensack M, Duerksen DR. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol 2000;95:2801-2806.

11. Heidelbaugh J, Inadomi J. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Amer J Gastroenterol 2006;101:2200-2205.

12. Lynda S. Overview of pharmacologic agents for acid suppression in critically ill patients. Am J Health Syst Pharm 2005;62(10 Suppl 2):s11-s17.

13. Cook DJ. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001;5:368-375.